Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?
A growing body of evidence has implicated oxidative stress as an important factor in the neuropathology associated with Parkinson's disease. Dopaminergic nigrostriatal neurons, the predominant cells lost in Parkinson's, are believed to be highly prone to oxidative damage due to the propensity for dopamine to auto-oxidize and thereby produce elevated levels of hydrogen peroxide and catecholamine quinones. Hydrogen peroxide formed during this process can either be converted by iron to form highly reactive hydroxyl radicals or removed through reduction by glutathione. Glutathione can also conjugate with quinones formed during dopamine oxidation preventing them from facilitating the release of iron from the iron-storage molecule ferritin. Alterations in both iron and glutathione levels in the substantia nigra have been correlated with the neuronal degeneration accompanying Parkinson's disease but a direct causative role for either has yet to be definitively proved. We will discuss the use of genetically engineered cell and mouse lines generated in our laboratory as models to examine the role that alterations in iron and glutathione levels may play in neurodegeneration of dopaminergic neurons of the substantia nigra associated with Parkinson's disease, and how these two parameters may interact with one another to bring this about.
Andrus Gerontology Center, University of Southern California, Los Angeles, CA 90089-0191, USA.
J K
JK
Andersen
D000818:Animals; D005978:Glutathione / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D007501:Iron / Q000378:metabolism* / Q000502:physiology; D051379:Mice; D010300:Parkinson Disease / Q000378:metabolism / Q000473:pathology*
D007501:Iron; D005978:Glutathione